Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection

Background: Glucantime is regarded as the first-line treatment of cutaneous leishmaniasis (CL); however, failure to treatment is a problem in many cases. Aim: The aim was to evaluate the therapeutic effect of glucantime in CL complicated with secondary bacterial infection compared to uncomplicated l...

Full description

Bibliographic Details
Main Authors: G Sadeghian, H Ziaei, L Shirani Bidabadi, A Zolfaghari Baghbaderani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=1;spage=37;epage=39;aulast=Sadeghian
_version_ 1819230916100227072
author G Sadeghian
H Ziaei
L Shirani Bidabadi
A Zolfaghari Baghbaderani
author_facet G Sadeghian
H Ziaei
L Shirani Bidabadi
A Zolfaghari Baghbaderani
author_sort G Sadeghian
collection DOAJ
description Background: Glucantime is regarded as the first-line treatment of cutaneous leishmaniasis (CL); however, failure to treatment is a problem in many cases. Aim: The aim was to evaluate the therapeutic effect of glucantime in CL complicated with secondary bacterial infection compared to uncomplicated lesions. Methods: This experimental study was performed in Skin Diseases and Leishmaniasis Research Center, Isfahan, Iran. A total of 161 patients enrolled in the study had CL confirmed by positive smear of lesions. All the patients were treated with systemic glucantime for 3 weeks and followed for 2 months. Response to treatment was defined as loss of infiltration, reepithelization, and negative smear. Depending on the results of bacterial cultures, the lesions were divided into two groups and the efficacy of glucantime was compared. Results: A total of 123 patients (76.4%) were negative, and 38 patients (23.6%) were positive for secondary bacterial infection. In groups with negative bacterial culture response to treatment was 65% (80 patients) and in the other positive group, it was 31.6% (12 patients), with a difference (χ2 = 13.77, P < 0.01). Conclusion: Therapeutic effect of glucantime showed a decrease in CL lesions with secondary bacterial infection. Therefore, in the cases of unresponsiveness to treatment, the lesions should be evaluated for bacterial infection, before repeating the treatment.
first_indexed 2024-12-23T11:36:40Z
format Article
id doaj.art-beaa73369cb84ecbbb92787159785978
institution Directory Open Access Journal
issn 0019-5154
1998-3611
language English
last_indexed 2024-12-23T11:36:40Z
publishDate 2011-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Dermatology
spelling doaj.art-beaa73369cb84ecbbb927871597859782022-12-21T17:48:38ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112011-01-01561373910.4103/0019-5154.77549Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infectionG SadeghianH ZiaeiL Shirani BidabadiA Zolfaghari BaghbaderaniBackground: Glucantime is regarded as the first-line treatment of cutaneous leishmaniasis (CL); however, failure to treatment is a problem in many cases. Aim: The aim was to evaluate the therapeutic effect of glucantime in CL complicated with secondary bacterial infection compared to uncomplicated lesions. Methods: This experimental study was performed in Skin Diseases and Leishmaniasis Research Center, Isfahan, Iran. A total of 161 patients enrolled in the study had CL confirmed by positive smear of lesions. All the patients were treated with systemic glucantime for 3 weeks and followed for 2 months. Response to treatment was defined as loss of infiltration, reepithelization, and negative smear. Depending on the results of bacterial cultures, the lesions were divided into two groups and the efficacy of glucantime was compared. Results: A total of 123 patients (76.4%) were negative, and 38 patients (23.6%) were positive for secondary bacterial infection. In groups with negative bacterial culture response to treatment was 65% (80 patients) and in the other positive group, it was 31.6% (12 patients), with a difference (χ2 = 13.77, P < 0.01). Conclusion: Therapeutic effect of glucantime showed a decrease in CL lesions with secondary bacterial infection. Therefore, in the cases of unresponsiveness to treatment, the lesions should be evaluated for bacterial infection, before repeating the treatment.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=1;spage=37;epage=39;aulast=SadeghianBacterial infectioncutaneous leishmaniasisglucantime
spellingShingle G Sadeghian
H Ziaei
L Shirani Bidabadi
A Zolfaghari Baghbaderani
Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
Indian Journal of Dermatology
Bacterial infection
cutaneous leishmaniasis
glucantime
title Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
title_full Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
title_fullStr Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
title_full_unstemmed Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
title_short Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
title_sort decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
topic Bacterial infection
cutaneous leishmaniasis
glucantime
url http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=1;spage=37;epage=39;aulast=Sadeghian
work_keys_str_mv AT gsadeghian decreasedeffectofglucantimeincutaneousleishmaniasiscomplicatedwithsecondarybacterialinfection
AT hziaei decreasedeffectofglucantimeincutaneousleishmaniasiscomplicatedwithsecondarybacterialinfection
AT lshiranibidabadi decreasedeffectofglucantimeincutaneousleishmaniasiscomplicatedwithsecondarybacterialinfection
AT azolfagharibaghbaderani decreasedeffectofglucantimeincutaneousleishmaniasiscomplicatedwithsecondarybacterialinfection